After teaming up in a partnership last year, the Serum Institute of Life Sciences is doubling its stake in biosimilar manufacturer Biocon Biologics to $300 million. The two agreed in September to form ...

As part of its expansion of investment in one of Biocon Ltd's units, Serum Institute of Life Sciences will give it access to 100 million vaccine doses annually. Biocon's unit will also have the ...

Vaccine-maker Serum Institute of India’s subsidiary Serum Institute Life Sciences and biotechnological company Biocon Biologics, a subsidiary of Biocon, have restructured their equity investment.

A unit of Adar Poonawalla-led Serum Institute of India, the world's biggest vaccine maker, will double its investment to $300 million (Rs 2,458 crore) in one of Biocon Ltd's subsidiaries that is also ...

Serum Institute of Life Sciences would make an additional equity investment of $150 million in Biocon Biologics Limited. The two firms have agreed to restructure equity investment as part of their ...

Add Yahoo as a preferred source to see more of our stories on Google. BENGALURU (Reuters) - The Serum Institute of Life Sciences will double its investment in one of Biocon Ltd's units, giving it ...

BENGALURU (Reuters) - The Serum Institute of Life Sciences will double its investment in one of Biocon Ltd's units, giving it access to 100 million doses of vaccines annually along with the ...

BENGALURU, April 25 (Reuters) - The Serum Institute of Life Sciences will double its investment in one of Biocon Ltd (BION.NS), opens new tab's units, giving it access to 100 million doses of vaccines ...